TP53 and neoplasm: In our current study and in previous reports, overexpression of Sgt1 in tumor tissues and xenografts was observed.22, 23Sgt1 heterozygous knockout decreased Hras-mediated transformation and tumorigenicity of p53−/− MEF cells and extended the survival period of p53−/− mice.